Related Experiment Videos
Immune checkpoint inhibitor-induced myo-fasciitis
Dimitrios Daoussis1, Pantelis Kraniotis2, Stamatis-Nick Liossis1
1Division of Rheumatology, Department of Internal Medicine.
Rheumatology (Oxford, England)
|October 14, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
CRP at diagnosis in psoriatic arthritis: what it means and associations with long-term outcomes.
Rheumatology (Oxford, England)·2026
GLP-1 receptor agonists in osteoarthritis and psoriatic disease: the missing link between obesity and inflammation?
Rheumatology international·2026
Late-onset psoriatic arthritis: data from a nationwide cross-sectional study.
Therapeutic advances in musculoskeletal disease·2025
Intravenous Immunoglobulin in Acute Exacerbations of Fibrotic Interstitial Lung Diseases: A Retrospective, Real-World Study.
Medicina (Kaunas, Lithuania)·2025
68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.
Rheumatology (Oxford, England)·2026
Radiomic analysis of high-resolution computed tomography predicts interstitial lung disease progression and mortality in systemic sclerosis.
Rheumatology (Oxford, England)·2026
Anti-Ro52 antibodies in idiopathic inflammatory myopathies: clinical significance across myositis-specific antibody-defined subgroups.
Rheumatology (Oxford, England)·2026
The thrombotic burden of high-risk immune thrombocytopenia patients receiving second-line treatments: a systematic review.
Rheumatology (Oxford, England)·2026
Real-world experience with obinutuzumab in difficult-to-treat myositis: concise report of a case series.
Rheumatology (Oxford, England)·2026
Self-efficacy in idiopathic inflammatory myopathies: associated factors, profiles, and patient-reported outcomes.
Rheumatology (Oxford, England)·2026
B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges.
Expert opinion on biological therapy·2026